Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Multiple Myeloma 1Head and Neck Neoplasms 1

Interventions

Flow Cytometry 2talactoferrin alfa 1perifosine 1cabozantinib 1antineoplaston AS 2-1 1antineoplaston A10 1alovudine 1alectinib 1Vorinostat 1Trastuzumab 1Tissue Array Analysis 1Taxes 1Sunitinib 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Paclitaxel 1Oxaliplatin 1Oligonucleotide Array Sequence Analysis 1Microarray Analysis 1Mass Spectrometry 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Immunoenzyme Techniques 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fluorescent Antibody Technique 1Everolimus 1Electroacupuncture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Salivary Gland Neoplasms × perifosine × Clear all
NCT00062387 2013-06-03

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
46 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡